经导管心臟瓣膜市场:各产品类型，各输送给药系统，各终端用户，各地区-规模，占有率，展望，机会分析，2023～2030年

市场动态

为了扩大产品组合，市场主要参与者越来越多地采用收购等无机增长策略，预计这将在预测期内推动市场增长。例如，2020年6月，医疗器械製造商SMT宣布通过收购结构心臟器械公司Vascular Concepts进入该市场。

本调查的主要特征

• 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球经导管心臟瓣膜市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球经导管心臟瓣膜市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球经导管心臟瓣膜市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球经导管心臟瓣膜市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称

第2章 市场展望

• 报告概要
  • 市场定义和范围
• 摘要整理
• 连贯·机遇·地图(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 主要的焦点
• 产品的销售
• 技术的进步
• PEST分析
• 法律规章方案
• M&A

第4章 经导管心臟瓣膜的全球市场-冠状病毒(COVID-19)的大流行病的影响

• 经济影响
• 关于COVID-19流行病学
• 需求与供给的影响

第5章 经导管心臟瓣膜的全球市场:各产品类型，2017年～2030年

• TAVR
• TMVR的介绍

第6章 经导管心臟瓣膜的全球市场:各输送给药系统，2017年～2030年

• 佛经大腿部方法
• 佛经胸墙方法
• 佛经主动脉方法

第7章 经导管心臟瓣膜的全球市场:各终端用户，2017年～2030年

• 医院
• 门诊病人手术中心
• 心导管检验设施
• 其他(专门医院等)

第8章 经导管心臟瓣膜的全球市场，各地区，2017年～2030年

• 北美
• 美国
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他南美国家
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 中东地区
• GCC
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第9章 竞争情形

• Edwards Lifesciences Corporation
• Medtronic
• Boston Scientific Corporation
• Abbott
• JenaValve Technology
• SYMETIS
• Braile Biomedica
• CryoLife, Inc.
• Shockwave Medical Inc.
• Venus Medtech(Hangzhou)Inc.

第10章 章节

• 关于调查手法
• 关于出版社

Transcatheter heart valve implantation is a minimally-invasive heart procedure to repair damaged heart valves with bio-prosthetic valves for treatment of valvular heart disease (VHD). It is an alternative approach to conventional open heart surgery and is especially recommended for extremely high risk patients. The aortic valve is located between the left lower heart chamber (left ventricle) and the body's main artery (aorta). If the valve does not open correctly, blood flow from the heart to the body is reduced. Transcatheter aortic valve replacement (TAVR) is approved by the U.S. FDA for treating individuals suffering from symptomatic aortic stenosis and are at high risk for standard valve replacement surgery. TAVR can help restore blood flow and reduce the signs and symptoms of aortic valve stenosis - such as chest pain, shortness of breath, fainting and fatigue. TAVR may be an option for people who are at risk of complications from surgical aortic valve replacement (open-heart surgery). Increasing demand for minimally-invasive procedures is expected to boost growth of the global transcatheter heart valve market over the forecast period.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2020, SMT, a manufacturer of medical equipment, announced that it has acquired structural heart medical device firm Vascular Concepts, to enter into the market.

Key features of the study:

• This report provides in-depth analysis of the global transcatheter heart valve market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global transcatheter heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott, JenaValve Technology, SYMETIS, Braile Biomedica, CryoLife, Inc., Shockwave Medical Inc., Venus Medtech (Hangzhou) Inc.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global transcatheter heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcatheter heart valve market

Detailed Segmentation:

• Global Transcatheter Heart Valve Market, By Product Type:
• TAVR
• TMVR
• Global Transcatheter Heart Valve Market, By Delivery Systems:
• Transfemoral Approach
• Transapical Approach
• Transaortic Approach
• Global Transcatheter Heart Valve Market, By End User:
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratory
• Other (Specialty Center, etc.)
• Global Transcatheter Heart Valve Market, By Region:
• North America
  • By Country:
• U.S.
• Canada
• Latin America
  • By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • By Country:
• GCC
• Israel
• Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Edwards Lifesciences Corporation*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Medtronic
  • Boston Scientific Corporation
  • Abbott, JenaValve Technology
  • SYMETIS
  • Braile Biomedica
  • CryoLife, Inc.
  • Shockwave Medical Inc.
  • Venus Medtech (Hangzhou) Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Delivery Systems
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product Launch
• Technological Advancements
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global Transcatheter Heart Valve Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Transcatheter Heart Valve Market, By Product Type, 2017 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• TAVR
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• TMVR
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

6. Global Transcatheter Heart Valve Market, By Delivery Systems, 2017 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Transfemoral Approach
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Transapical Approach
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Transaortic Approach
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

7. Global Transcatheter Heart Valve Market, By End User, 2017 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Ambulatory Surgical Center
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Cardiac Catheterization Laboratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
• Others (Specialty Center, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

8. Global Transcatheter Heart Valve Market, By Region, 2017 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Billion)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Edwards Lifesciences Corporation*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• JenaValve Technology
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• SYMETIS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Braile Biomedica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CryoLife, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Shockwave Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Venus Medtech (Hangzhou) Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us